[HTML][HTML] Misoprostol use in obstetrics: Number 6–June 2023
NSC on Childbirth, NSC on High-Risk… - RBGO Gynecology & …, 2023 - ncbi.nlm.nih.gov
Background Misoprostol is a synthetic analogue of prostaglandin E1 (PGE1) with gastric
secretion inhibitory and mucosal protection properties through the production of bicarbonate …
secretion inhibitory and mucosal protection properties through the production of bicarbonate …
Misoprostol use in obstetrics: Number 6-June 2023
RMY Nomura, M Nakamura-Pereira… - Revista Brasileira de …, 2023 - SciELO Brasil
Background Misoprostol is a synthetic analogue of prostaglandin E1 (PGE1) with gastric
secretion inhibitory and mucosal protection properties through the production of bicarbonate …
secretion inhibitory and mucosal protection properties through the production of bicarbonate …
Misoprostol Use in Pregnancy—An Update
DC Young, JMG Crane, D Hutchens, KA Bennett… - Journal SOGC, 1999 - Elsevier
Misoprostol is an inexpensive prostaglandin E 1 analogue marketed for oral prophylaxis and
management of upper gastro-intestinal disorders, particularly those associated with …
management of upper gastro-intestinal disorders, particularly those associated with …
Misoprostol and pregnancy: ever-increasing indications of effective usage
AU Lokugamage, H El Refaey… - Current Opinion in …, 2003 - journals.lww.com
Misoprostol and pregnancy: ever-increasing indications of ef... : Current Opinion in Obstetrics
and Gynecology Misoprostol and pregnancy: ever-increasing indications of effective usage …
and Gynecology Misoprostol and pregnancy: ever-increasing indications of effective usage …
Adverse effects of misprostol in pregnancy
S Züst, I Hösli, D Surbek, W Holzgreve - Zeitschrift fur Geburtshilfe …, 2001 - europepmc.org
Background Although Misoprostol is an already widely used medication in gynecology and
obstetrics, extended studies on dosage and safety are still missing. As far as the application …
obstetrics, extended studies on dosage and safety are still missing. As far as the application …
[PDF][PDF] FIGO's updated recommendations for misoprostol used alone in gynecology and obstetrics
1| BACKGROUND In 2012, the International Federation of Obstetrics and Gynecology
(FIGO) produced a chart detailing recommended dosages of misoprostol when used alone …
(FIGO) produced a chart detailing recommended dosages of misoprostol when used alone …
[PDF][PDF] Obstetric use of misoprostol: Innovations, evidence, controversy and global health perspectives
GJ Hofmeyr - 2015 - wiredspace.wits.ac.za
Objective: To assess the effectiveness and safety of the administration of misoprostol. an
orally active prostaglandin. in addition to routine uterotonic therapy as part of the active …
orally active prostaglandin. in addition to routine uterotonic therapy as part of the active …
Use of misoprostol in obstetrics and gynecology
J Song - Obstetrical & Gynecological Survey, 2000 - journals.lww.com
Misoprostol is prostaglandin E 1 analogous and marketed for prevention and treatment of
peptic ulcer disease. However, it has been used widely in obstetrics and gynecology …
peptic ulcer disease. However, it has been used widely in obstetrics and gynecology …
Misoprostol and pregnancy
AB Goldberg, MB Greenberg… - New England Journal of …, 2001 - Mass Medical Soc
Misoprostol is a prostaglandin E1 analogue that has been approved by the Food and Drug
Administration (FDA) to be taken orally for the prevention and treatment of gastric ulcers …
Administration (FDA) to be taken orally for the prevention and treatment of gastric ulcers …
[Adverse effects of misprostol in pregnancy]. Review. Z Geburtshilfe Neonatol. 2001 Mar-Apr; 205 (2): 43-8.
S Zust, I Hosli, D Surbek, W Holzgreve - Z Geburtshilfe Neonatol, 2001 - afar.info
BACKGROUND: Although Misoprostol is an already widely used medication in gynecology
and obstetrics, extended studies on dosage and safety are still missing. As far as the …
and obstetrics, extended studies on dosage and safety are still missing. As far as the …